Press Releases

PAVmed Subsidiary Lucid Diagnostics Receives FDA 510(k) Clearance for EsoCheck™

Jun 24, 2019 10:46am EDT

PAVmed Reports First Quarter 2019 Financial Results and Provides Business Update

May 21, 2019 9:30am EDT

PAVmed Announces First Human CarpX™ Procedures

May 20, 2019 9:30am EDT

PAVmed to Hold Business Update Conference Call on May 21, 2019

May 06, 2019 9:30am EDT

PAVmed Reports Excellent DisappEAR™ Animal Study Results

Apr 24, 2019 9:30am EDT

PAVmed Announces Registered Direct Offering of its Common Stock

Apr 12, 2019 9:35am EDT

PAVmed Reports Fourth Quarter 2018 Financial Results and Provides Business Update

Apr 04, 2019 9:30am EDT

PAVmed to Hold Business Update Conference Call on April 4, 2019

Mar 21, 2019 7:30am EDT

PAVmed Announces NextFlo™ Breakthrough

Mar 20, 2019 7:30am EDT

PAVmed Announces PortIO™ Breakthrough

Mar 13, 2019 8:04am EDT